nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—urinary bladder cancer	0.335	1	CiPCiCtD
Cisplatin—testicular cancer—urinary bladder cancer	0.158	1	CtDrD
Cisplatin—MT1A—urinary bladder cancer	0.0731	0.35	CbGaD
Cisplatin—MT2A—urinary bladder cancer	0.0471	0.225	CbGaD
Cisplatin—SLC31A2—Carboplatin—urinary bladder cancer	0.0214	0.104	CbGbCtD
Cisplatin—NQO1—urinary bladder cancer	0.0205	0.0981	CbGaD
Cisplatin—GSTT1—urinary bladder cancer	0.0192	0.0918	CbGaD
Cisplatin—GSTM1—urinary bladder cancer	0.0164	0.0784	CbGaD
Cisplatin—ATP7A—Carboplatin—urinary bladder cancer	0.0155	0.0753	CbGbCtD
Cisplatin—ATP7B—Carboplatin—urinary bladder cancer	0.0155	0.0753	CbGbCtD
Cisplatin—MT2A—Carboplatin—urinary bladder cancer	0.0155	0.0753	CbGbCtD
Cisplatin—MT1A—Carboplatin—urinary bladder cancer	0.0155	0.0753	CbGbCtD
Cisplatin—GSTP1—urinary bladder cancer	0.0152	0.0725	CbGaD
Cisplatin—MPO—urinary bladder cancer	0.0128	0.0612	CbGaD
Cisplatin—SOD1—Carboplatin—urinary bladder cancer	0.0123	0.0598	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—urinary bladder cancer	0.0123	0.0598	CbGbCtD
Cisplatin—GSTT1—Carboplatin—urinary bladder cancer	0.0103	0.0501	CbGbCtD
Cisplatin—GSTM1—Carboplatin—urinary bladder cancer	0.00888	0.0433	CbGbCtD
Cisplatin—GSTT1—Etoposide—urinary bladder cancer	0.00863	0.042	CbGbCtD
Cisplatin—NQO1—Carboplatin—urinary bladder cancer	0.00706	0.0344	CbGbCtD
Cisplatin—GSTP1—Carboplatin—urinary bladder cancer	0.00642	0.0313	CbGbCtD
Cisplatin—GSTP1—Etoposide—urinary bladder cancer	0.00539	0.0263	CbGbCtD
Cisplatin—ABCC6—Etoposide—urinary bladder cancer	0.00496	0.0241	CbGbCtD
Cisplatin—PTGS2—urinary bladder cancer	0.0048	0.0229	CbGaD
Cisplatin—ABCC5—Fluorouracil—urinary bladder cancer	0.00454	0.0221	CbGbCtD
Cisplatin—NQO1—Doxorubicin—urinary bladder cancer	0.00404	0.0197	CbGbCtD
Cisplatin—XDH—Carboplatin—urinary bladder cancer	0.00369	0.018	CbGbCtD
Cisplatin—MPO—Carboplatin—urinary bladder cancer	0.00369	0.018	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—urinary bladder cancer	0.00338	0.0165	CbGbCtD
Cisplatin—ABCC3—Fluorouracil—urinary bladder cancer	0.00285	0.0139	CbGbCtD
Cisplatin—CYP2B6—Thiotepa—urinary bladder cancer	0.00254	0.0124	CbGbCtD
Cisplatin—ABCC3—Etoposide—urinary bladder cancer	0.00238	0.0116	CbGbCtD
Cisplatin—XDH—Doxorubicin—urinary bladder cancer	0.00211	0.0103	CbGbCtD
Cisplatin—ABCB1—Mitomycin—urinary bladder cancer	0.00172	0.00836	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—urinary bladder cancer	0.00162	0.00791	CbGbCtD
Cisplatin—ABCC3—Methotrexate—urinary bladder cancer	0.00157	0.00766	CbGbCtD
Cisplatin—ABCC2—Carboplatin—urinary bladder cancer	0.00129	0.00628	CbGbCtD
Cisplatin—ABCG2—Fluorouracil—urinary bladder cancer	0.00117	0.00571	CbGbCtD
Cisplatin—ABCG2—Carboplatin—urinary bladder cancer	0.00117	0.00568	CbGbCtD
Cisplatin—ABCC2—Etoposide—urinary bladder cancer	0.00108	0.00527	CbGbCtD
Cisplatin—PTGS2—Etoposide—urinary bladder cancer	0.00107	0.00521	CbGbCtD
Cisplatin—GSTT1—urine—urinary bladder cancer	0.00107	0.0526	CbGeAlD
Cisplatin—ABCG2—Etoposide—urinary bladder cancer	0.000979	0.00476	CbGbCtD
Cisplatin—GSTM1—urine—urinary bladder cancer	0.000786	0.0387	CbGeAlD
Cisplatin—ABCC2—Doxorubicin—urinary bladder cancer	0.000738	0.00359	CbGbCtD
Cisplatin—ABCC2—Methotrexate—urinary bladder cancer	0.000715	0.00348	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—urinary bladder cancer	0.000667	0.00325	CbGbCtD
Cisplatin—ABCG2—Methotrexate—urinary bladder cancer	0.000647	0.00315	CbGbCtD
Cisplatin—ABCB1—Gemcitabine—urinary bladder cancer	0.000494	0.00241	CbGbCtD
Cisplatin—GSTP1—urine—urinary bladder cancer	0.000493	0.0243	CbGeAlD
Cisplatin—ABCC6—Podofilox—Etoposide—urinary bladder cancer	0.000489	1	CbGdCrCtD
Cisplatin—MT1A—prostate gland—urinary bladder cancer	0.00047	0.0232	CbGeAlD
Cisplatin—CYP2B6—Doxorubicin—urinary bladder cancer	0.000469	0.00229	CbGbCtD
Cisplatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.000436	0.00212	CbGbCtD
Cisplatin—ATP7B—prostate gland—urinary bladder cancer	0.000421	0.0207	CbGeAlD
Cisplatin—MT2A—prostate gland—urinary bladder cancer	0.000392	0.0193	CbGeAlD
Cisplatin—SLC31A2—prostate gland—urinary bladder cancer	0.000385	0.019	CbGeAlD
Cisplatin—GSTT1—prostate gland—urinary bladder cancer	0.000383	0.0189	CbGeAlD
Cisplatin—ABCB1—Etoposide—urinary bladder cancer	0.000353	0.00172	CbGbCtD
Cisplatin—ATP7A—prostate gland—urinary bladder cancer	0.000339	0.0167	CbGeAlD
Cisplatin—SLC31A2—seminal vesicle—urinary bladder cancer	0.000326	0.016	CbGeAlD
Cisplatin—MT1A—renal system—urinary bladder cancer	0.00032	0.0158	CbGeAlD
Cisplatin—SOD1—prostate gland—urinary bladder cancer	0.000297	0.0146	CbGeAlD
Cisplatin—CYP4A11—renal system—urinary bladder cancer	0.000295	0.0145	CbGeAlD
Cisplatin—SLC31A1—prostate gland—urinary bladder cancer	0.000289	0.0142	CbGeAlD
Cisplatin—ATP7A—seminal vesicle—urinary bladder cancer	0.000287	0.0141	CbGeAlD
Cisplatin—XDH—prostate gland—urinary bladder cancer	0.000286	0.0141	CbGeAlD
Cisplatin—GSTM1—prostate gland—urinary bladder cancer	0.000282	0.0139	CbGeAlD
Cisplatin—ATP7B—urethra—urinary bladder cancer	0.000282	0.0139	CbGeAlD
Cisplatin—MT2A—renal system—urinary bladder cancer	0.000267	0.0131	CbGeAlD
Cisplatin—CYP2C9—urine—urinary bladder cancer	0.000263	0.013	CbGeAlD
Cisplatin—GSTT1—renal system—urinary bladder cancer	0.000261	0.0129	CbGeAlD
Cisplatin—SLC31A2—urethra—urinary bladder cancer	0.000258	0.0127	CbGeAlD
Cisplatin—MT1A—female reproductive system—urinary bladder cancer	0.000257	0.0126	CbGeAlD
Cisplatin—SOD1—seminal vesicle—urinary bladder cancer	0.000251	0.0124	CbGeAlD
Cisplatin—ATP7A—epithelium—urinary bladder cancer	0.000249	0.0123	CbGeAlD
Cisplatin—SLC31A1—seminal vesicle—urinary bladder cancer	0.000245	0.012	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—urinary bladder cancer	0.000241	0.00117	CbGbCtD
Cisplatin—ABCB1—Methotrexate—urinary bladder cancer	0.000233	0.00114	CbGbCtD
Cisplatin—ATP7A—renal system—urinary bladder cancer	0.000231	0.0114	CbGeAlD
Cisplatin—ATP7B—female reproductive system—urinary bladder cancer	0.00023	0.0113	CbGeAlD
Cisplatin—ATP7A—urethra—urinary bladder cancer	0.000227	0.0112	CbGeAlD
Cisplatin—CYP4A11—vagina—urinary bladder cancer	0.000214	0.0105	CbGeAlD
Cisplatin—MT2A—female reproductive system—urinary bladder cancer	0.000214	0.0105	CbGeAlD
Cisplatin—ABCC6—renal system—urinary bladder cancer	0.000212	0.0104	CbGeAlD
Cisplatin—ABCC5—prostate gland—urinary bladder cancer	0.000211	0.0104	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—urinary bladder cancer	0.00021	0.0103	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—urinary bladder cancer	0.00021	0.0103	CbGeAlD
Cisplatin—GSTT1—female reproductive system—urinary bladder cancer	0.000209	0.0103	CbGeAlD
Cisplatin—ATP7B—vagina—urinary bladder cancer	0.000208	0.0102	CbGeAlD
Cisplatin—SOD1—urethra—urinary bladder cancer	0.000199	0.00979	CbGeAlD
Cisplatin—NQO1—prostate gland—urinary bladder cancer	0.000198	0.00974	CbGeAlD
Cisplatin—SLC31A1—renal system—urinary bladder cancer	0.000197	0.00971	CbGeAlD
Cisplatin—XDH—renal system—urinary bladder cancer	0.000195	0.00959	CbGeAlD
Cisplatin—SLC31A1—urethra—urinary bladder cancer	0.000194	0.00954	CbGeAlD
Cisplatin—GSTM1—renal system—urinary bladder cancer	0.000192	0.00948	CbGeAlD
Cisplatin—SLC31A2—vagina—urinary bladder cancer	0.00019	0.00936	CbGeAlD
Cisplatin—ABCC3—prostate gland—urinary bladder cancer	0.000178	0.00875	CbGeAlD
Cisplatin—GSTP1—prostate gland—urinary bladder cancer	0.000177	0.00871	CbGeAlD
Cisplatin—ATP7A—vagina—urinary bladder cancer	0.000167	0.00824	CbGeAlD
Cisplatin—NQO1—seminal vesicle—urinary bladder cancer	0.000167	0.00824	CbGeAlD
Cisplatin—SLC31A1—female reproductive system—urinary bladder cancer	0.000158	0.00778	CbGeAlD
Cisplatin—XDH—female reproductive system—urinary bladder cancer	0.000156	0.00768	CbGeAlD
Cisplatin—GSTM1—female reproductive system—urinary bladder cancer	0.000154	0.00759	CbGeAlD
Cisplatin—SLC22A2—renal system—urinary bladder cancer	0.000153	0.00752	CbGeAlD
Cisplatin—MT1A—lymph node—urinary bladder cancer	0.00015	0.00739	CbGeAlD
Cisplatin—GSTP1—seminal vesicle—urinary bladder cancer	0.00015	0.00737	CbGeAlD
Cisplatin—SOD1—vagina—urinary bladder cancer	0.000147	0.00722	CbGeAlD
Cisplatin—NQO1—epithelium—urinary bladder cancer	0.000145	0.00716	CbGeAlD
Cisplatin—SLC31A1—vagina—urinary bladder cancer	0.000143	0.00703	CbGeAlD
Cisplatin—ABCC2—prostate gland—urinary bladder cancer	0.000142	0.00699	CbGeAlD
Cisplatin—XDH—vagina—urinary bladder cancer	0.000141	0.00695	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—urinary bladder cancer	0.00014	0.0069	CbGeAlD
Cisplatin—NQO1—renal system—urinary bladder cancer	0.000135	0.00664	CbGeAlD
Cisplatin—ATP7B—lymph node—urinary bladder cancer	0.000135	0.00662	CbGeAlD
Cisplatin—MPO—epithelium—urinary bladder cancer	0.000134	0.00658	CbGeAlD
Cisplatin—NQO1—urethra—urinary bladder cancer	0.000132	0.00652	CbGeAlD
Cisplatin—GSTP1—epithelium—urinary bladder cancer	0.00013	0.0064	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—urinary bladder cancer	0.000125	0.00617	CbGeAlD
Cisplatin—MPO—renal system—urinary bladder cancer	0.000124	0.00611	CbGeAlD
Cisplatin—SLC31A2—lymph node—urinary bladder cancer	0.000123	0.00605	CbGeAlD
Cisplatin—ABCC3—renal system—urinary bladder cancer	0.000121	0.00596	CbGeAlD
Cisplatin—GSTP1—renal system—urinary bladder cancer	0.000121	0.00594	CbGeAlD
Cisplatin—GSTP1—urethra—urinary bladder cancer	0.000118	0.00583	CbGeAlD
Cisplatin—ATP7A—lymph node—urinary bladder cancer	0.000108	0.00533	CbGeAlD
Cisplatin—NQO1—female reproductive system—urinary bladder cancer	0.000108	0.00532	CbGeAlD
Cisplatin—BCHE—prostate gland—urinary bladder cancer	0.000107	0.00527	CbGeAlD
Cisplatin—ABCC5—vagina—urinary bladder cancer	0.000104	0.00514	CbGeAlD
Cisplatin—ABCG2—prostate gland—urinary bladder cancer	0.000103	0.0051	CbGeAlD
Cisplatin—NQO1—vagina—urinary bladder cancer	9.77e-05	0.00481	CbGeAlD
Cisplatin—ABCC3—female reproductive system—urinary bladder cancer	9.69e-05	0.00477	CbGeAlD
Cisplatin—ABCC2—renal system—urinary bladder cancer	9.67e-05	0.00476	CbGeAlD
Cisplatin—GSTP1—female reproductive system—urinary bladder cancer	9.65e-05	0.00475	CbGeAlD
Cisplatin—SOD1—lymph node—urinary bladder cancer	9.48e-05	0.00467	CbGeAlD
Cisplatin—SLC31A1—lymph node—urinary bladder cancer	9.24e-05	0.00455	CbGeAlD
Cisplatin—BCHE—seminal vesicle—urinary bladder cancer	9.06e-05	0.00446	CbGeAlD
Cisplatin—GSTM1—lymph node—urinary bladder cancer	9.01e-05	0.00444	CbGeAlD
Cisplatin—ABCG2—seminal vesicle—urinary bladder cancer	8.75e-05	0.00431	CbGeAlD
Cisplatin—GSTP1—vagina—urinary bladder cancer	8.73e-05	0.0043	CbGeAlD
Cisplatin—PTGS2—prostate gland—urinary bladder cancer	8.25e-05	0.00406	CbGeAlD
Cisplatin—ABCC2—female reproductive system—urinary bladder cancer	7.74e-05	0.00381	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—urinary bladder cancer	7.58e-05	0.00373	CbGeAlD
Cisplatin—PTGS2—seminal vesicle—urinary bladder cancer	6.98e-05	0.00344	CbGeAlD
Cisplatin—ABCG2—urethra—urinary bladder cancer	6.93e-05	0.00341	CbGeAlD
Cisplatin—ABCC5—lymph node—urinary bladder cancer	6.75e-05	0.00333	CbGeAlD
Cisplatin—CYP2B6—renal system—urinary bladder cancer	6.51e-05	0.0032	CbGeAlD
Cisplatin—NQO1—lymph node—urinary bladder cancer	6.32e-05	0.00311	CbGeAlD
Cisplatin—PTGS2—epithelium—urinary bladder cancer	6.06e-05	0.00299	CbGeAlD
Cisplatin—BCHE—female reproductive system—urinary bladder cancer	5.84e-05	0.00288	CbGeAlD
Cisplatin—PTGS2—smooth muscle tissue—urinary bladder cancer	5.84e-05	0.00288	CbGeAlD
Cisplatin—MPO—lymph node—urinary bladder cancer	5.81e-05	0.00286	CbGeAlD
Cisplatin—ABCC3—lymph node—urinary bladder cancer	5.67e-05	0.00279	CbGeAlD
Cisplatin—GSTP1—lymph node—urinary bladder cancer	5.65e-05	0.00278	CbGeAlD
Cisplatin—PTGS2—renal system—urinary bladder cancer	5.62e-05	0.00277	CbGeAlD
Cisplatin—PTGS2—urethra—urinary bladder cancer	5.52e-05	0.00272	CbGeAlD
Cisplatin—BCHE—vagina—urinary bladder cancer	5.29e-05	0.0026	CbGeAlD
Cisplatin—CYP2B6—female reproductive system—urinary bladder cancer	5.21e-05	0.00257	CbGeAlD
Cisplatin—CYP2C9—female reproductive system—urinary bladder cancer	5.16e-05	0.00254	CbGeAlD
Cisplatin—ABCG2—vagina—urinary bladder cancer	5.11e-05	0.00252	CbGeAlD
Cisplatin—ABCB1—prostate gland—urinary bladder cancer	5.1e-05	0.00251	CbGeAlD
Cisplatin—CYP2B6—vagina—urinary bladder cancer	4.71e-05	0.00232	CbGeAlD
Cisplatin—ABCC2—lymph node—urinary bladder cancer	4.53e-05	0.00223	CbGeAlD
Cisplatin—PTGS2—female reproductive system—urinary bladder cancer	4.5e-05	0.00222	CbGeAlD
Cisplatin—ABCB1—seminal vesicle—urinary bladder cancer	4.32e-05	0.00213	CbGeAlD
Cisplatin—PTGS2—vagina—urinary bladder cancer	4.07e-05	0.00201	CbGeAlD
Cisplatin—ABCB1—epithelium—urinary bladder cancer	3.75e-05	0.00185	CbGeAlD
Cisplatin—ABCB1—renal system—urinary bladder cancer	3.48e-05	0.00171	CbGeAlD
Cisplatin—BCHE—lymph node—urinary bladder cancer	3.42e-05	0.00168	CbGeAlD
Cisplatin—ABCB1—urethra—urinary bladder cancer	3.42e-05	0.00168	CbGeAlD
Cisplatin—ABCG2—lymph node—urinary bladder cancer	3.3e-05	0.00163	CbGeAlD
Cisplatin—ABCB1—female reproductive system—urinary bladder cancer	2.79e-05	0.00137	CbGeAlD
Cisplatin—PTGS2—lymph node—urinary bladder cancer	2.63e-05	0.0013	CbGeAlD
Cisplatin—ABCB1—vagina—urinary bladder cancer	2.52e-05	0.00124	CbGeAlD
Cisplatin—Leukopenia—Etoposide—urinary bladder cancer	2.22e-05	0.000592	CcSEcCtD
Cisplatin—Hypotension—Gemcitabine—urinary bladder cancer	2.21e-05	0.000591	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	2.2e-05	0.000589	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	2.17e-05	0.000582	CcSEcCtD
Cisplatin—Hypotension—Fluorouracil—urinary bladder cancer	2.17e-05	0.000581	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—urinary bladder cancer	2.16e-05	0.000577	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	2.15e-05	0.000576	CcSEcCtD
Cisplatin—Convulsion—Etoposide—urinary bladder cancer	2.14e-05	0.000573	CcSEcCtD
Cisplatin—Dehydration—Epirubicin—urinary bladder cancer	2.14e-05	0.000573	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—urinary bladder cancer	2.14e-05	0.000572	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	2.13e-05	0.00057	CcSEcCtD
Cisplatin—Paraesthesia—Gemcitabine—urinary bladder cancer	2.12e-05	0.000568	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	2.12e-05	0.000567	CcSEcCtD
Cisplatin—Dyspnoea—Gemcitabine—urinary bladder cancer	2.11e-05	0.000564	CcSEcCtD
Cisplatin—Orthostatic hypotension—Epirubicin—urinary bladder cancer	2.1e-05	0.000563	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—urinary bladder cancer	2.1e-05	0.000561	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	2.09e-05	0.00056	CcSEcCtD
Cisplatin—Paraesthesia—Fluorouracil—urinary bladder cancer	2.09e-05	0.000558	CcSEcCtD
Cisplatin—Pancreatitis—Methotrexate—urinary bladder cancer	2.09e-05	0.000558	CcSEcCtD
Cisplatin—Discomfort—Etoposide—urinary bladder cancer	2.08e-05	0.000557	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—urinary bladder cancer	2.08e-05	0.000557	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	2.07e-05	0.000555	CcSEcCtD
Cisplatin—Dyspnoea—Fluorouracil—urinary bladder cancer	2.07e-05	0.000554	CcSEcCtD
Cisplatin—Hypersensitivity—Thiotepa—urinary bladder cancer	2.07e-05	0.000554	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—urinary bladder cancer	2.06e-05	0.000551	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—urinary bladder cancer	2.06e-05	0.00055	CcSEcCtD
Cisplatin—Decreased appetite—Gemcitabine—urinary bladder cancer	2.06e-05	0.00055	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	2.04e-05	0.000546	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—urinary bladder cancer	2.04e-05	0.000545	CcSEcCtD
Cisplatin—Pain—Gemcitabine—urinary bladder cancer	2.02e-05	0.000541	CcSEcCtD
Cisplatin—Decreased appetite—Fluorouracil—urinary bladder cancer	2.02e-05	0.000541	CcSEcCtD
Cisplatin—Pancytopenia—Methotrexate—urinary bladder cancer	2.02e-05	0.00054	CcSEcCtD
Cisplatin—Anaphylactic shock—Etoposide—urinary bladder cancer	2.02e-05	0.00054	CcSEcCtD
Cisplatin—Asthenia—Thiotepa—urinary bladder cancer	2.02e-05	0.000539	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	2.01e-05	0.000537	CcSEcCtD
Cisplatin—Infection—Etoposide—urinary bladder cancer	2.01e-05	0.000537	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—urinary bladder cancer	2e-05	0.000534	CcSEcCtD
Cisplatin—Pain—Fluorouracil—urinary bladder cancer	1.99e-05	0.000532	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—urinary bladder cancer	1.98e-05	0.00053	CcSEcCtD
Cisplatin—Thrombocytopenia—Etoposide—urinary bladder cancer	1.98e-05	0.000529	CcSEcCtD
Cisplatin—Tachycardia—Etoposide—urinary bladder cancer	1.97e-05	0.000527	CcSEcCtD
Cisplatin—Skin disorder—Etoposide—urinary bladder cancer	1.96e-05	0.000525	CcSEcCtD
Cisplatin—Hyperhidrosis—Etoposide—urinary bladder cancer	1.95e-05	0.000522	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—urinary bladder cancer	1.95e-05	0.000522	CcSEcCtD
Cisplatin—Feeling abnormal—Gemcitabine—urinary bladder cancer	1.95e-05	0.000521	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	1.95e-05	0.000521	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—urinary bladder cancer	1.94e-05	0.000519	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—urinary bladder cancer	1.93e-05	0.000515	CcSEcCtD
Cisplatin—Anorexia—Etoposide—urinary bladder cancer	1.93e-05	0.000515	CcSEcCtD
Cisplatin—Diarrhoea—Thiotepa—urinary bladder cancer	1.92e-05	0.000514	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	1.92e-05	0.000513	CcSEcCtD
Cisplatin—Feeling abnormal—Fluorouracil—urinary bladder cancer	1.92e-05	0.000512	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—urinary bladder cancer	1.91e-05	0.00051	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—urinary bladder cancer	1.89e-05	0.000506	CcSEcCtD
Cisplatin—Hypotension—Etoposide—urinary bladder cancer	1.89e-05	0.000505	CcSEcCtD
Cisplatin—Body temperature increased—Gemcitabine—urinary bladder cancer	1.87e-05	0.0005	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—urinary bladder cancer	1.86e-05	0.000499	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—urinary bladder cancer	1.85e-05	0.000494	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—urinary bladder cancer	1.84e-05	0.000493	CcSEcCtD
Cisplatin—Body temperature increased—Fluorouracil—urinary bladder cancer	1.84e-05	0.000492	CcSEcCtD
Cisplatin—Paraesthesia—Etoposide—urinary bladder cancer	1.81e-05	0.000485	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—urinary bladder cancer	1.81e-05	0.000483	CcSEcCtD
Cisplatin—Dyspnoea—Etoposide—urinary bladder cancer	1.8e-05	0.000481	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	1.79e-05	0.00048	CcSEcCtD
Cisplatin—Vomiting—Thiotepa—urinary bladder cancer	1.79e-05	0.000478	CcSEcCtD
Cisplatin—Rash—Thiotepa—urinary bladder cancer	1.77e-05	0.000474	CcSEcCtD
Cisplatin—Dermatitis—Thiotepa—urinary bladder cancer	1.77e-05	0.000474	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—urinary bladder cancer	1.76e-05	0.000469	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—urinary bladder cancer	1.75e-05	0.000468	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—urinary bladder cancer	1.74e-05	0.000467	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	1.74e-05	0.000466	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	1.74e-05	0.000465	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—urinary bladder cancer	1.73e-05	0.000463	CcSEcCtD
Cisplatin—Pain—Etoposide—urinary bladder cancer	1.73e-05	0.000462	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—urinary bladder cancer	1.73e-05	0.000461	CcSEcCtD
Cisplatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	1.71e-05	0.000458	CcSEcCtD
Cisplatin—Asthenia—Gemcitabine—urinary bladder cancer	1.7e-05	0.000454	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—urinary bladder cancer	1.68e-05	0.00045	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	1.68e-05	0.000449	CcSEcCtD
Cisplatin—Nausea—Thiotepa—urinary bladder cancer	1.67e-05	0.000447	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—urinary bladder cancer	1.67e-05	0.000446	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—urinary bladder cancer	1.66e-05	0.000445	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—urinary bladder cancer	1.64e-05	0.000439	CcSEcCtD
Cisplatin—ABCB1—lymph node—urinary bladder cancer	1.63e-05	0.000802	CbGeAlD
Cisplatin—Bradycardia—Epirubicin—urinary bladder cancer	1.62e-05	0.000434	CcSEcCtD
Cisplatin—Diarrhoea—Gemcitabine—urinary bladder cancer	1.62e-05	0.000433	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—urinary bladder cancer	1.61e-05	0.000432	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	1.61e-05	0.000431	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—urinary bladder cancer	1.6e-05	0.000428	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—urinary bladder cancer	1.6e-05	0.000427	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—urinary bladder cancer	1.6e-05	0.000427	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—urinary bladder cancer	1.59e-05	0.000426	CcSEcCtD
Cisplatin—Diarrhoea—Fluorouracil—urinary bladder cancer	1.59e-05	0.000425	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—urinary bladder cancer	1.59e-05	0.000425	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—urinary bladder cancer	1.58e-05	0.000423	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—urinary bladder cancer	1.57e-05	0.000421	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—urinary bladder cancer	1.57e-05	0.000419	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—urinary bladder cancer	1.56e-05	0.000418	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	1.55e-05	0.000415	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—urinary bladder cancer	1.54e-05	0.000411	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—urinary bladder cancer	1.54e-05	0.000411	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—urinary bladder cancer	1.53e-05	0.00041	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—urinary bladder cancer	1.5e-05	0.000402	CcSEcCtD
Cisplatin—Vomiting—Gemcitabine—urinary bladder cancer	1.5e-05	0.000402	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—urinary bladder cancer	1.5e-05	0.000401	CcSEcCtD
Cisplatin—Rash—Gemcitabine—urinary bladder cancer	1.49e-05	0.000399	CcSEcCtD
Cisplatin—Dermatitis—Gemcitabine—urinary bladder cancer	1.49e-05	0.000398	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—urinary bladder cancer	1.49e-05	0.000398	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—urinary bladder cancer	1.49e-05	0.000398	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—urinary bladder cancer	1.49e-05	0.000397	CcSEcCtD
Cisplatin—Erythema—Methotrexate—urinary bladder cancer	1.48e-05	0.000396	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—urinary bladder cancer	1.48e-05	0.000396	CcSEcCtD
Cisplatin—Flushing—Epirubicin—urinary bladder cancer	1.48e-05	0.000395	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—urinary bladder cancer	1.48e-05	0.000395	CcSEcCtD
Cisplatin—Vomiting—Fluorouracil—urinary bladder cancer	1.48e-05	0.000395	CcSEcCtD
Cisplatin—Rash—Fluorouracil—urinary bladder cancer	1.47e-05	0.000392	CcSEcCtD
Cisplatin—Dermatitis—Fluorouracil—urinary bladder cancer	1.46e-05	0.000392	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	1.46e-05	0.000389	CcSEcCtD
Cisplatin—Asthenia—Etoposide—urinary bladder cancer	1.45e-05	0.000387	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	1.45e-05	0.000387	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—urinary bladder cancer	1.45e-05	0.000386	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—urinary bladder cancer	1.44e-05	0.000385	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—urinary bladder cancer	1.44e-05	0.000384	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—urinary bladder cancer	1.42e-05	0.000381	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—urinary bladder cancer	1.42e-05	0.00038	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—urinary bladder cancer	1.41e-05	0.000377	CcSEcCtD
Cisplatin—Nausea—Gemcitabine—urinary bladder cancer	1.4e-05	0.000376	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—urinary bladder cancer	1.4e-05	0.000374	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—urinary bladder cancer	1.39e-05	0.000371	CcSEcCtD
Cisplatin—Erythema—Epirubicin—urinary bladder cancer	1.39e-05	0.000371	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—urinary bladder cancer	1.38e-05	0.00037	CcSEcCtD
Cisplatin—Nausea—Fluorouracil—urinary bladder cancer	1.38e-05	0.000369	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—urinary bladder cancer	1.38e-05	0.000368	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—urinary bladder cancer	1.38e-05	0.000368	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—urinary bladder cancer	1.37e-05	0.000368	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—urinary bladder cancer	1.37e-05	0.000366	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—urinary bladder cancer	1.37e-05	0.000366	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—urinary bladder cancer	1.37e-05	0.000366	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—urinary bladder cancer	1.37e-05	0.000366	CcSEcCtD
Cisplatin—Malaise—Methotrexate—urinary bladder cancer	1.34e-05	0.000357	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—urinary bladder cancer	1.33e-05	0.000357	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—urinary bladder cancer	1.33e-05	0.000356	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	1.33e-05	0.000355	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—urinary bladder cancer	1.33e-05	0.000355	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—urinary bladder cancer	1.32e-05	0.000352	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—urinary bladder cancer	1.31e-05	0.00035	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—urinary bladder cancer	1.3e-05	0.000348	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—urinary bladder cancer	1.29e-05	0.000344	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—urinary bladder cancer	1.28e-05	0.000343	CcSEcCtD
Cisplatin—Vomiting—Etoposide—urinary bladder cancer	1.28e-05	0.000343	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—urinary bladder cancer	1.28e-05	0.000343	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—urinary bladder cancer	1.28e-05	0.000343	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—urinary bladder cancer	1.28e-05	0.000343	CcSEcCtD
Cisplatin—Rash—Etoposide—urinary bladder cancer	1.27e-05	0.000341	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—urinary bladder cancer	1.27e-05	0.00034	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—urinary bladder cancer	1.26e-05	0.000338	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—urinary bladder cancer	1.26e-05	0.000337	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	1.25e-05	0.000335	CcSEcCtD
Cisplatin—Malaise—Epirubicin—urinary bladder cancer	1.25e-05	0.000335	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—urinary bladder cancer	1.25e-05	0.000333	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—urinary bladder cancer	1.24e-05	0.000332	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—urinary bladder cancer	1.23e-05	0.00033	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—urinary bladder cancer	1.21e-05	0.000323	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—urinary bladder cancer	1.21e-05	0.000323	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—urinary bladder cancer	1.2e-05	0.000321	CcSEcCtD
Cisplatin—Infection—Methotrexate—urinary bladder cancer	1.2e-05	0.000321	CcSEcCtD
Cisplatin—Nausea—Etoposide—urinary bladder cancer	1.2e-05	0.000321	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	1.19e-05	0.000318	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—urinary bladder cancer	1.19e-05	0.000317	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—urinary bladder cancer	1.19e-05	0.000317	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—urinary bladder cancer	1.18e-05	0.000317	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—urinary bladder cancer	1.18e-05	0.000316	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—urinary bladder cancer	1.18e-05	0.000315	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—urinary bladder cancer	1.18e-05	0.000314	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	1.17e-05	0.000314	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—urinary bladder cancer	1.17e-05	0.000313	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—urinary bladder cancer	1.17e-05	0.000312	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—urinary bladder cancer	1.16e-05	0.00031	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—urinary bladder cancer	1.15e-05	0.000308	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—urinary bladder cancer	1.15e-05	0.000307	CcSEcCtD
Cisplatin—Oedema—Epirubicin—urinary bladder cancer	1.13e-05	0.000303	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—urinary bladder cancer	1.13e-05	0.000303	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—urinary bladder cancer	1.13e-05	0.000302	CcSEcCtD
Cisplatin—Infection—Epirubicin—urinary bladder cancer	1.12e-05	0.000301	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—urinary bladder cancer	1.11e-05	0.000297	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—urinary bladder cancer	1.11e-05	0.000297	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—urinary bladder cancer	1.11e-05	0.000296	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—urinary bladder cancer	1.1e-05	0.000295	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	1.1e-05	0.000295	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—urinary bladder cancer	1.1e-05	0.000294	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—urinary bladder cancer	1.09e-05	0.000293	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—urinary bladder cancer	1.09e-05	0.000292	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—urinary bladder cancer	1.09e-05	0.000291	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—urinary bladder cancer	1.09e-05	0.00029	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	1.09e-05	0.00029	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—urinary bladder cancer	1.08e-05	0.000289	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—urinary bladder cancer	1.08e-05	0.000289	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—urinary bladder cancer	1.08e-05	0.000288	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—urinary bladder cancer	1.06e-05	0.000283	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—urinary bladder cancer	1.05e-05	0.000281	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	1.05e-05	0.00028	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—urinary bladder cancer	1.05e-05	0.00028	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	1.04e-05	0.000279	CcSEcCtD
Cisplatin—Infection—Doxorubicin—urinary bladder cancer	1.04e-05	0.000278	CcSEcCtD
Cisplatin—Pain—Methotrexate—urinary bladder cancer	1.03e-05	0.000277	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	1.03e-05	0.000276	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—urinary bladder cancer	1.03e-05	0.000275	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	1.03e-05	0.000274	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—urinary bladder cancer	1.02e-05	0.000273	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—urinary bladder cancer	1.02e-05	0.000272	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—urinary bladder cancer	1.02e-05	0.000272	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	1.01e-05	0.000271	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—urinary bladder cancer	1.01e-05	0.00027	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—urinary bladder cancer	9.98e-06	0.000267	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—urinary bladder cancer	9.97e-06	0.000267	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—urinary bladder cancer	9.84e-06	0.000263	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—urinary bladder cancer	9.79e-06	0.000262	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.77e-06	0.000261	CcSEcCtD
Cisplatin—Pain—Epirubicin—urinary bladder cancer	9.68e-06	0.000259	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—urinary bladder cancer	9.56e-06	0.000256	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	9.54e-06	0.000255	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—urinary bladder cancer	9.41e-06	0.000252	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—urinary bladder cancer	9.34e-06	0.00025	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—urinary bladder cancer	9.33e-06	0.000249	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—urinary bladder cancer	9.11e-06	0.000244	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	9.04e-06	0.000242	CcSEcCtD
Cisplatin—Pain—Doxorubicin—urinary bladder cancer	8.96e-06	0.00024	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—urinary bladder cancer	8.95e-06	0.000239	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—urinary bladder cancer	8.91e-06	0.000238	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—urinary bladder cancer	8.68e-06	0.000232	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.63e-06	0.000231	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—urinary bladder cancer	8.34e-06	0.000223	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—urinary bladder cancer	8.28e-06	0.000221	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—urinary bladder cancer	8.28e-06	0.000221	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—urinary bladder cancer	8.12e-06	0.000217	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—urinary bladder cancer	7.75e-06	0.000207	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.72e-06	0.000206	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—urinary bladder cancer	7.69e-06	0.000206	CcSEcCtD
Cisplatin—Rash—Methotrexate—urinary bladder cancer	7.63e-06	0.000204	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—urinary bladder cancer	7.62e-06	0.000204	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—urinary bladder cancer	7.52e-06	0.000201	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—urinary bladder cancer	7.2e-06	0.000192	CcSEcCtD
Cisplatin—Nausea—Methotrexate—urinary bladder cancer	7.19e-06	0.000192	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—urinary bladder cancer	7.17e-06	0.000192	CcSEcCtD
Cisplatin—Rash—Epirubicin—urinary bladder cancer	7.14e-06	0.000191	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—urinary bladder cancer	7.13e-06	0.000191	CcSEcCtD
Cisplatin—Nausea—Epirubicin—urinary bladder cancer	6.72e-06	0.00018	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—urinary bladder cancer	6.66e-06	0.000178	CcSEcCtD
Cisplatin—Rash—Doxorubicin—urinary bladder cancer	6.6e-06	0.000177	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—urinary bladder cancer	6.6e-06	0.000176	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—urinary bladder cancer	6.22e-06	0.000166	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—TYMS—urinary bladder cancer	1.92e-06	5.63e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.91e-06	5.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.91e-06	5.59e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMP—urinary bladder cancer	1.9e-06	5.57e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	1.9e-06	5.57e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTM1—urinary bladder cancer	1.9e-06	5.57e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NCOR1—urinary bladder cancer	1.9e-06	5.57e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.89e-06	5.54e-05	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.88e-06	5.52e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PPARG—urinary bladder cancer	1.87e-06	5.49e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	1.87e-06	5.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.87e-06	5.47e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.83e-06	5.37e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	1.83e-06	5.37e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMP—urinary bladder cancer	1.83e-06	5.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.83e-06	5.35e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PPARG—urinary bladder cancer	1.83e-06	5.35e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.83e-06	5.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	1.83e-06	5.35e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GPX1—urinary bladder cancer	1.82e-06	5.33e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO2—urinary bladder cancer	1.8e-06	5.28e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HPGDS—urinary bladder cancer	1.8e-06	5.28e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CREBBP—urinary bladder cancer	1.8e-06	5.28e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CREBBP—urinary bladder cancer	1.8e-06	5.28e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ERCC2—urinary bladder cancer	1.79e-06	5.24e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	1.78e-06	5.23e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO2—urinary bladder cancer	1.78e-06	5.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.78e-06	5.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTP1—urinary bladder cancer	1.76e-06	5.15e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CREBBP—urinary bladder cancer	1.75e-06	5.14e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTT1—urinary bladder cancer	1.75e-06	5.13e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.74e-06	5.1e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—urinary bladder cancer	1.73e-06	5.08e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	1.73e-06	5.07e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	1.73e-06	5.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.72e-06	5.05e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NAT2—urinary bladder cancer	1.72e-06	5.04e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.71e-06	5.02e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.7e-06	4.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.69e-06	4.94e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—MTHFR—urinary bladder cancer	1.68e-06	4.92e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NAT2—urinary bladder cancer	1.65e-06	4.85e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.65e-06	4.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO2—urinary bladder cancer	1.64e-06	4.81e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PPARG—urinary bladder cancer	1.64e-06	4.8e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.64e-06	4.8e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TYMS—urinary bladder cancer	1.63e-06	4.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RHOA—urinary bladder cancer	1.63e-06	4.78e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—IGF1—urinary bladder cancer	1.63e-06	4.77e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.62e-06	4.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.62e-06	4.74e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTM1—urinary bladder cancer	1.62e-06	4.73e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NCOR1—urinary bladder cancer	1.62e-06	4.73e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NQO1—urinary bladder cancer	1.61e-06	4.72e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.6e-06	4.68e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.59e-06	4.67e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.58e-06	4.62e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CREBBP—urinary bladder cancer	1.57e-06	4.61e-05	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—urinary bladder cancer	1.57e-06	4.61e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARG—urinary bladder cancer	1.57e-06	4.6e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.56e-06	4.58e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RBX1—urinary bladder cancer	1.56e-06	4.56e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GPX1—urinary bladder cancer	1.55e-06	4.53e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.53e-06	4.49e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ERCC2—urinary bladder cancer	1.52e-06	4.45e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.52e-06	4.45e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—urinary bladder cancer	1.51e-06	4.43e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CREBBP—urinary bladder cancer	1.51e-06	4.42e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—urinary bladder cancer	1.51e-06	4.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.48e-06	4.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.48e-06	4.33e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—urinary bladder cancer	1.47e-06	4.32e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—urinary bladder cancer	1.47e-06	4.32e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NQO1—urinary bladder cancer	1.45e-06	4.26e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—EP300—urinary bladder cancer	1.44e-06	4.23e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NQO1—urinary bladder cancer	1.44e-06	4.22e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—urinary bladder cancer	1.44e-06	4.21e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MTHFR—urinary bladder cancer	1.43e-06	4.18e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	1.43e-06	4.18e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	1.4e-06	4.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JAG1—urinary bladder cancer	1.39e-06	4.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO2—urinary bladder cancer	1.37e-06	4.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HPGDS—urinary bladder cancer	1.37e-06	4.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.37e-06	4.01e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.36e-06	3.99e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—urinary bladder cancer	1.36e-06	3.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.35e-06	3.95e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—urinary bladder cancer	1.34e-06	3.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.33e-06	3.91e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.32e-06	3.88e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.32e-06	3.87e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.32e-06	3.87e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.31e-06	3.85e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—urinary bladder cancer	1.31e-06	3.84e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CREBBP—urinary bladder cancer	1.31e-06	3.83e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.3e-06	3.81e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.29e-06	3.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1A—urinary bladder cancer	1.29e-06	3.78e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—urinary bladder cancer	1.29e-06	3.78e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—urinary bladder cancer	1.29e-06	3.77e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—urinary bladder cancer	1.29e-06	3.77e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.28e-06	3.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.26e-06	3.7e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.26e-06	3.69e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—urinary bladder cancer	1.25e-06	3.67e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TYMS—urinary bladder cancer	1.25e-06	3.66e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—urinary bladder cancer	1.24e-06	3.62e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTM1—urinary bladder cancer	1.23e-06	3.62e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NCOR1—urinary bladder cancer	1.23e-06	3.62e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.23e-06	3.61e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EP300—urinary bladder cancer	1.23e-06	3.6e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—EP300—urinary bladder cancer	1.23e-06	3.59e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.22e-06	3.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.22e-06	3.57e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.21e-06	3.55e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.21e-06	3.55e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	1.2e-06	3.52e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—EP300—urinary bladder cancer	1.19e-06	3.5e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SRC—urinary bladder cancer	1.19e-06	3.5e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GPX1—urinary bladder cancer	1.18e-06	3.46e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ERCC2—urinary bladder cancer	1.16e-06	3.4e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—urinary bladder cancer	1.16e-06	3.39e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.14e-06	3.34e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.13e-06	3.3e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—urinary bladder cancer	1.12e-06	3.29e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TYMS—urinary bladder cancer	1.12e-06	3.27e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.11e-06	3.26e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.11e-06	3.26e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CREBBP—urinary bladder cancer	1.11e-06	3.26e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.11e-06	3.25e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	1.1e-06	3.23e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	1.1e-06	3.23e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—urinary bladder cancer	1.09e-06	3.2e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.09e-06	3.18e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—urinary bladder cancer	1.08e-06	3.16e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—EP300—urinary bladder cancer	1.07e-06	3.14e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—urinary bladder cancer	1.07e-06	3.14e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—urinary bladder cancer	1.07e-06	3.13e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.07e-06	3.13e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.07e-06	3.12e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GPX1—urinary bladder cancer	1.06e-06	3.09e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.05e-06	3.08e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.05e-06	3.07e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—urinary bladder cancer	1.05e-06	3.06e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	1.04e-06	3.04e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—EP300—urinary bladder cancer	1.03e-06	3.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NCOR1—urinary bladder cancer	1.01e-06	2.97e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—urinary bladder cancer	9.88e-07	2.9e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—urinary bladder cancer	9.84e-07	2.89e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	9.83e-07	2.88e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—urinary bladder cancer	9.75e-07	2.86e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	9.75e-07	2.86e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	9.74e-07	2.86e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERCC2—urinary bladder cancer	9.54e-07	2.8e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	9.45e-07	2.77e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.38e-07	2.75e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—urinary bladder cancer	9.34e-07	2.74e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—urinary bladder cancer	9.24e-07	2.71e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—urinary bladder cancer	9.11e-07	2.67e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	9.11e-07	2.67e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	9.11e-07	2.67e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.05e-07	2.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—urinary bladder cancer	8.96e-07	2.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.94e-07	2.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—urinary bladder cancer	8.94e-07	2.62e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—urinary bladder cancer	8.91e-07	2.61e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	8.88e-07	2.6e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.85e-07	2.59e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—urinary bladder cancer	8.84e-07	2.59e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	8.83e-07	2.59e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.7e-07	2.55e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMS—urinary bladder cancer	8.59e-07	2.52e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CREBBP—urinary bladder cancer	8.5e-07	2.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NCOR1—urinary bladder cancer	8.49e-07	2.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—urinary bladder cancer	8.49e-07	2.49e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—urinary bladder cancer	8.4e-07	2.46e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	8.26e-07	2.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR3—urinary bladder cancer	8.2e-07	2.4e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	8.16e-07	2.39e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	8.16e-07	2.39e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPX1—urinary bladder cancer	8.13e-07	2.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ERCC2—urinary bladder cancer	7.99e-07	2.34e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—urinary bladder cancer	7.98e-07	2.34e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—urinary bladder cancer	7.94e-07	2.33e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—urinary bladder cancer	7.9e-07	2.32e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NQO1—urinary bladder cancer	7.86e-07	2.3e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	7.82e-07	2.29e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	7.68e-07	2.25e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CREBBP—urinary bladder cancer	7.67e-07	2.25e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	7.59e-07	2.22e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—urinary bladder cancer	7.57e-07	2.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—urinary bladder cancer	7.51e-07	2.2e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	7.34e-07	2.15e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	7.22e-07	2.11e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.12e-07	2.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CREBBP—urinary bladder cancer	6.98e-07	2.05e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—urinary bladder cancer	6.96e-07	2.04e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	6.55e-07	1.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RHOA—urinary bladder cancer	6.32e-07	1.85e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—urinary bladder cancer	6.28e-07	1.84e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	6.21e-07	1.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.21e-07	1.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.12e-07	1.79e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMS—urinary bladder cancer	6.09e-07	1.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—urinary bladder cancer	6.09e-07	1.78e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—urinary bladder cancer	6.07e-07	1.78e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	6.02e-07	1.77e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	6.02e-07	1.77e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.92e-07	1.74e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	5.85e-07	1.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CREBBP—urinary bladder cancer	5.85e-07	1.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—urinary bladder cancer	5.85e-07	1.71e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—urinary bladder cancer	5.79e-07	1.7e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPX1—urinary bladder cancer	5.77e-07	1.69e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	5.69e-07	1.67e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	5.66e-07	1.66e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	5.63e-07	1.65e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	5.63e-07	1.65e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	5.62e-07	1.65e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—urinary bladder cancer	5.48e-07	1.61e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—urinary bladder cancer	5.42e-07	1.59e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	5.39e-07	1.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	5.32e-07	1.56e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	5.29e-07	1.55e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—urinary bladder cancer	5.22e-07	1.53e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—urinary bladder cancer	5.17e-07	1.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—urinary bladder cancer	5e-07	1.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—urinary bladder cancer	4.99e-07	1.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.97e-07	1.46e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—urinary bladder cancer	4.76e-07	1.39e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SRC—urinary bladder cancer	4.62e-07	1.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	4.6e-07	1.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—urinary bladder cancer	4.32e-07	1.26e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—urinary bladder cancer	4.18e-07	1.22e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	4.15e-07	1.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—urinary bladder cancer	4.14e-07	1.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—urinary bladder cancer	4.05e-07	1.19e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.03e-07	1.18e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	4.01e-07	1.18e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—urinary bladder cancer	3.98e-07	1.17e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.87e-07	1.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—urinary bladder cancer	3.83e-07	1.12e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—urinary bladder cancer	3.83e-07	1.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.39e-07	9.95e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—urinary bladder cancer	3.25e-07	9.54e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.17e-07	9.3e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.96e-07	8.68e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—urinary bladder cancer	2.82e-07	8.28e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.77e-07	8.11e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.64e-07	7.73e-06	CbGpPWpGaD
